Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-019-01412-2
Abstract: BackgroundTo compare the prognostic outcomes between first-generation antiandrogen (FGA) and novel androgen-receptor-axis-targeted agent (ARATA) as first-line therapy in patients with non-metastatic castration-resistant prostate cancer (nmCRPC).MethodsThis study retrospectively included a total of 103 consecutive nmCRPC patients… read more here.
Keywords: prostate; prognostic outcomes; androgen; line ... See more keywords
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-019-01613-9
Abstract: Background Prognostic outcomes and safety following treatment with pembrolizumab in patients with advanced urothelial carcinoma (UC) have not been fully elucidated in clinical practice. The aim of this study was to evaluate the oncological efficacy… read more here.
Keywords: prognostic outcomes; safety; outcomes safety; advanced urothelial ... See more keywords
Prognostic outcomes of OSCC derived from proliferative verrucous leukoplakia: a systematic review.
Sign Up to like & getrecommendations! Published in 2022 at "Oral diseases"
DOI: 10.1111/odi.14171
Abstract: OBJECTIVE This study aimed to evaluate prognostic outcomes of PVL-derived oral squamous cell carcinomas (P-OSCC) based on recurrence, new primary tumour, metastasis and survival information. STUDY DESIGN Five databases and grey literature were searched electronically… read more here.
Keywords: outcomes oscc; proliferative verrucous; systematic review; prognostic outcomes ... See more keywords
Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-020-09022-3
Abstract: The prediction of prognostic outcomes can provide the most suitable strategy for patients with pancreatic ductal adenocarcinoma (PDAC). This study aimed to evaluate the clinical value of the preoperative tumor marker index (pre-TI) in predicting… read more here.
Keywords: prognostic outcomes; pre; pancreatic ductal; ductal adenocarcinoma ... See more keywords